What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in SAEs ‐ overall analysis (low certainty).

• Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia 2012 · Cochrane Headline outcomes only
  RR 1.05 [0.89, 1.23]
  2 studies · 598 participants
  Low